Статья

Do nsaids cause specific complications in COVID-19 coronavirus infection?

A. Karateev, E. Nasonov, A. Lila,
2021

Currently, there is no clear data indicating the risk of specific complications when using non-steroidal anti-inflammatory drugs (NSAIDs), and in particular ibuprofen, for COVID-19 infection. There is also no clear clinical evidence that taking NSAIDs increases the risk of COVID-19 infection. However, when using NSAIDs in patients with acute respiratory viral diseases, keep in mind the possibility of class-specific complications from the gastrointestinal tract, cardiovascular system and kidneys. This risk is quite serious in elderly patients with multiple comorbid diseases. In addition, you should remember that taking NSAIDs and paracetamol can mask important symptoms of COVID-19 infection (in particular, fever) and lengthen the time for making a correct diagnosis. © 2020 Ima-Press Publishing House. All rights reserved.

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • A. Karateev
    V.A. Nasonova Research Institute of Rheumatology, 34A, Kashirskoe Shosse, Moscow, 115522, Russian Federation
  • E. Nasonov
    I.M. Sechenov First Moscow State Medical University, Sechenov University, Ministry of Health of Russia, 8, Trubetskaya St., Moscow, 119991, Russian Federation
  • A. Lila
    Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia, 2/1, Barrikadnaya St., Moscow, 125993, Russian Federation
Название журнала
  • Nauchno-Prakticheskaya Revmatologiya
Том
  • 58
Выпуск
  • 3
Страницы
  • 340-343
Ключевые слова
  • ibuprofen; paracetamol; Article; cardiovascular disease; comorbidity; coronavirus disease 2019; fever; gastrointestinal disease; human; kidney disease; risk factor
Издатель
  • Ima-Press Publishing House
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus